Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41,009,592
-
Total 13F shares
-
334,950
-
Share change
-
-208,770
-
Total reported value
-
$1,904,000
-
Put/Call ratio
-
29%
-
Price per share
-
$5.68
-
Number of holders
-
13
-
Value change
-
-$1,476,942
-
Number of buys
-
5
-
Number of sells
-
6
Institutional Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q2 2015
As of 30 Jun 2015,
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
334,950 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, GREYLIN INVESTMENT MANGEMENT INC, TOCQUEVILLE ASSET MANAGEMENT L.P., HSBC HOLDINGS PLC, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, FineMark National Bank & Trust, UBS Group AG, PNC Financial Services Group, Inc., and LADENBURG THALMANN FINANCIAL SERVICES INC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.